O slideshow foi denunciado.
Utilizamos seu perfil e dados de atividades no LinkedIn para personalizar e exibir anúncios mais relevantes. Altere suas preferências de anúncios quando desejar.

PharmD

1.429 visualizações

Publicada em

Pharm D

Publicada em: Saúde e medicina
  • Secrets To Working Online, Hundreds of online opportunites you can profit with today!  http://ishbv.com/ezpayjobs/pdf
       Responder 
    Tem certeza que deseja  Sim  Não
    Insira sua mensagem aqui

PharmD

  1. 1. Prajith.V PharmD @Sri Ramakrishna Institute of Paramedical Sciences Prajithkanna@gmail.com
  2. 2.  PCI President Dr B Suresh who brought Doctor of Pharmacy Program to India  About 62% of licensed pharmacists work in community pharmacies and 23% work in hospitals  About 71% of Pharmacy Technician jobs are in pharmacies, grocery stores, department stores, or mass retailers.
  3. 3.  Pharmacy council of India started the programme in the year 2008 with a good intention to improve the pharmacy services in the Indian healthcare system and to increase the dignity of the profession. But, from the beginning a group of people have been raising allegations about the way the programme was introduced and the way it is disturbing the smooth running of the course putting the students into a quandary.  http://www.acharya.ac.in/pharmd.html
  4. 4.  A Pharm D graduate could find jobs mostly related to the clinical force of India. With gradual amendments being made in the health care industry, the Pharm D graduate could play an active role in heading the Hospital Pharmacy Setting (Hospital Setting / Hospital Pharmacy.  Also with a large number of Pharmaceutical companies opting for clinical trials the industry is heading towards a business worth 1.4 billion by way of clinical trials.
  5. 5.  Hospital Pharmacy  Community Pharmacy  Clinical Pharmacy  Clinical Pharmacokinetics  Clinical trial safety
  6. 6. The Federation of Indian Pharmacists Organization (FIPO) has urged the Department of Personnel & Training (DoPT), government of India to revise the Rule 51 of the Central Civil Services Leave Rules (CCS) in order to facilitate the pharmacists in the central government health services to pursue higher studies in pharmacy, especially the three-year Pharm D (PB) programme
  7. 7.  Hospital Pharmacy  Community Pharmacy  Clinical Pharmacy  Clinical Pharmacokinetics  Clinical trial safety
  8. 8.  Pharmacovigilance  Pharmaco-economics  Adverse Drug Reactions (ADRs)  Clinical Research Organizations  Biostatistics and Research Methodology
  9. 9.  Clinical Toxicology  Clinical Research, Pharmacoepidemiology  Pharmacotherapeutic Drug Monitoring  Clinical Pharmacokinetics  Pharmacoeconomics  Drug Safety  Forensic Pharmacy  Forensic Psychology
  10. 10.  Foreign Pharmacy Graduate Examination Committee (FPGEC)
  11. 11. Surveillance Programmes In India
  12. 12. Introduction why Pharmacovigilance Aim of Pharmacovigilance Pharmacovigilance: Future Challenges, Need & issues Outcome of successful Program in Pharmacovigilance Summery & Conclusion
  13. 13. BY V . PRAJITH
  14. 14.  Pharmacovigilance Programme of India launched on July 14, 2010 is currently capturing ADR data in Indian population in a systematic way in coordination with the IPC. The main objective of the Programme is to monitor ADRs in Indian population.  Safety Monitoring of Medicinal Products  Pharmacovigilance (PV or PhV), also known as Drug Safety
  15. 15.  All medicines have risks as well as benefits. The aim of Pharmacovigilance 1 is to protect public health by identifying, evaluating, managing and minimizing safety Issues to ensure that the overall benefits of medicines outweigh the risks.  Patient safety is a fundamental principle  Apply computerized statistical tool s to facilitate the evaluation of safety information through, for example, the identification of unexpected adverse events that are being reported on a disproportionate basis (safety signals)  The science of Pharmacovigilance is continuously evolving and is actively involved in working with industry, regulators, healthcare professionals and patients to enhance methodologies in this area
  16. 16.  Drug Technical Advisory Board (DTAB) set up Vigilance Cells  Forensic Pharmacy and Forensic Psychology  Adverse Drug Reactions (ADRs)  Clinical Trial Safety
  17. 17.  In this regard, IPC which acts as the national coordination centre (NCC) for Pharmacovigilance Program of India (PvPI) already had a series of strategic meetings with the Centre over the last few months.  Since 2011, around 1,10,000 adverse drug reactions have been reported from across the country. However, this was after the government made it mandatory for hospitals to have a pharmacovigilance cell. Still, officials say, there are only few hospitals across the country operating with a proper cell.  Currently, there are only 150 hospitals across the country which have pharmacovigilance cell, the official cell. However, the health ministry and the drug regulator are making efforts to ramp up such cells.
  18. 18. Haemovigilance Meterio-Vigilance Bio-Vigilance
  19. 19. prajithkanna@gmail.com

×